Financial Toxicity Among Patients With Cancer-Where to From Here? (Editorial)

View/ Open
File version
Accepted Manuscript (AM)
Author(s)
Gordon, Louisa G
Chan, Raymond Javan
Griffith University Author(s)
Year published
2017
Metadata
Show full item recordAbstract
In oncology, the term “financial toxicity” means the financial hardship or financial burden for patients and families that arise from cancer treatment and ongoing expenses. Individuals from any socioeconomic group may experience this, and it can occur in both low- and high-income countries. There are 2 key contributors: (1) high medical payments by individuals/households and (2) reduced income while being treated or recovering from cancer. The former is likely to affect more individuals in high-income countries, whereas the latter is more problematic in poor households although, clearly, individuals will be worse when faced ...
View more >In oncology, the term “financial toxicity” means the financial hardship or financial burden for patients and families that arise from cancer treatment and ongoing expenses. Individuals from any socioeconomic group may experience this, and it can occur in both low- and high-income countries. There are 2 key contributors: (1) high medical payments by individuals/households and (2) reduced income while being treated or recovering from cancer. The former is likely to affect more individuals in high-income countries, whereas the latter is more problematic in poor households although, clearly, individuals will be worse when faced with both high out-of-pocket medical expenses (outgoings) and concurrent loss of earnings (incomings). In some studies, financial hardship is defined as spending greater than 30% of household income on healthcare and is termed “catastrophic spending.”1
View less >
View more >In oncology, the term “financial toxicity” means the financial hardship or financial burden for patients and families that arise from cancer treatment and ongoing expenses. Individuals from any socioeconomic group may experience this, and it can occur in both low- and high-income countries. There are 2 key contributors: (1) high medical payments by individuals/households and (2) reduced income while being treated or recovering from cancer. The former is likely to affect more individuals in high-income countries, whereas the latter is more problematic in poor households although, clearly, individuals will be worse when faced with both high out-of-pocket medical expenses (outgoings) and concurrent loss of earnings (incomings). In some studies, financial hardship is defined as spending greater than 30% of household income on healthcare and is termed “catastrophic spending.”1
View less >
Journal Title
Cancer Nursing
Volume
40
Issue
4
Copyright Statement
© 2017 Lippincott Williams & Wilkins. This is a non-final version of an article published in final form in Cancer Nursing, 2017, 40 (4), pp. 257-258. Reproduced in accordance with the copyright policy of the publisher. Please refer to the journal link for access to the definitive, published version.
Subject
Nursing
Oncology and carcinogenesis
Science & Technology
Life Sciences & Biomedicine
COST